Synklino
35 years of research experience (10 years in Oxford and Cambridge) & 20+ years in biotech. Extensive experience in building and leading biotech companies. Co-founder and former CSO of Symphogen, CEO of F-star Therapeutics.
This person is not in the org chart
This person is not in any offices
Synklino
1 followers
Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.